Learn More
ATCC Escherichia coli (Migula) Castellani and Chalmers - ATCC BAA-3303, drug-resistant bacterial strain (frozen vial)
Supplier: ATCC BAA3303
Escherichia coli clinically derived strain isolated from a human pancreas in 2014. The strain is genome sequenced and characterized for multiple antimicrobial resistance determinants; it is supplied frozen and must be handled under BSL-2 laboratory conditions. Common uses include antimicrobial resistance research, molecular assay development, and antimicrobial drug discovery.
- Clinically derived, isolated from human pancreas in 2014.
- Genome sequenced and annotated for multiple resistance genes.
- Phenotypically resistant to multiple commonly used antibiotics; includes a documented susceptibility profile.
- Supplied as a frozen vial; recommended storage at -80°C or colder.
- Recovery: incubate at 37°C for 18-24 hours on appropriate media.
- Handle under biosafety level 2 (BSL-2) containment and follow institutional safety protocols.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.